Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 2 | 2024 | 574 | 0.740 |
Why?
|
| Antineoplastic Agents | 4 | 2024 | 2366 | 0.510 |
Why?
|
| Retinal Neoplasms | 3 | 2020 | 14 | 0.510 |
Why?
|
| Retinoblastoma | 3 | 2020 | 31 | 0.500 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 760 | 0.460 |
Why?
|
| Ophthalmic Artery | 3 | 2020 | 6 | 0.380 |
Why?
|
| Infusions, Intra-Arterial | 3 | 2020 | 39 | 0.380 |
Why?
|
| Eflornithine | 2 | 2024 | 16 | 0.270 |
Why?
|
| Brain Ischemia | 2 | 2020 | 404 | 0.240 |
Why?
|
| Catheterization | 3 | 2020 | 237 | 0.230 |
Why?
|
| Radial Artery | 2 | 2021 | 36 | 0.220 |
Why?
|
| Spermine | 1 | 2024 | 25 | 0.210 |
Why?
|
| Polyamines | 1 | 2024 | 38 | 0.210 |
Why?
|
| Infant | 4 | 2022 | 3206 | 0.200 |
Why?
|
| Growth and Development | 1 | 2022 | 14 | 0.190 |
Why?
|
| KATP Channels | 1 | 2021 | 20 | 0.180 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 61 | 0.170 |
Why?
|
| Upper Extremity | 1 | 2021 | 62 | 0.170 |
Why?
|
| Insulin | 2 | 2022 | 1168 | 0.160 |
Why?
|
| Cytokines | 1 | 2024 | 842 | 0.160 |
Why?
|
| Intracranial Thrombosis | 1 | 2019 | 30 | 0.160 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 324 | 0.150 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 131 | 0.150 |
Why?
|
| Intracranial Aneurysm | 1 | 2021 | 200 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 183 | 0.150 |
Why?
|
| Glucose | 1 | 2021 | 683 | 0.140 |
Why?
|
| Embolization, Therapeutic | 1 | 2021 | 265 | 0.140 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 555 | 0.140 |
Why?
|
| Thrombectomy | 1 | 2019 | 198 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 270 | 0.130 |
Why?
|
| Infant, Newborn | 1 | 2022 | 2506 | 0.120 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 310 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 329 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 315 | 0.120 |
Why?
|
| Mice | 2 | 2024 | 12133 | 0.100 |
Why?
|
| Humans | 10 | 2024 | 92351 | 0.100 |
Why?
|
| Retrospective Studies | 6 | 2021 | 9694 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2021 | 8730 | 0.080 |
Why?
|
| Stroke | 1 | 2019 | 1038 | 0.080 |
Why?
|
| Mutation | 1 | 2022 | 4213 | 0.080 |
Why?
|
| Animals | 3 | 2024 | 28059 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2020 | 3806 | 0.080 |
Why?
|
| Adult | 2 | 2022 | 27547 | 0.060 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 2023 | 4 | 0.050 |
Why?
|
| Putrescine | 1 | 2023 | 7 | 0.050 |
Why?
|
| Ornithine Decarboxylase | 1 | 2023 | 10 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 2979 | 0.050 |
Why?
|
| Female | 6 | 2021 | 47901 | 0.050 |
Why?
|
| Amino Acids, Cyclic | 1 | 2021 | 2 | 0.050 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2021 | 17 | 0.050 |
Why?
|
| Potassium Chloride | 1 | 2021 | 87 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 224 | 0.040 |
Why?
|
| Biometry | 1 | 2021 | 68 | 0.040 |
Why?
|
| Carotid Artery, External | 1 | 2020 | 9 | 0.040 |
Why?
|
| Male | 5 | 2021 | 43928 | 0.040 |
Why?
|
| Angiography | 1 | 2021 | 206 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2021 | 524 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 1232 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 855 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 430 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 290 | 0.030 |
Why?
|
| Stents | 1 | 2019 | 417 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2903 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 1926 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1661 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1733 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1761 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 4073 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 807 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 3113 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 19952 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 3775 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 2368 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 27045 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5708 | 0.020 |
Why?
|